Abstract:
Cardiovascular disease (CVD) is the leading cause of death and disability worldwide. The primary prevention of CVD is dependent upon the ability to identify high-risk individuals long before the development of overt events. This highlights the need for accurate risk stratification.
For a number of years healthcare professionals have been using a wide range of traditional methods and tools for assessing and calculating individual’s predicted future risk for cardiovascular disease including coronary and cerebrovascular disease. They include taking into account presence of co-morbidities such as Diabetes Mellitus, Hypertension, Dyslipidaemia, smoking and family history. Risk scoring tools such as Framingham and Risk score and also utilization of some basic cardiac investigations. These methods have been useful but we realise that they always do not adequately and accurately predict the cardiovascular risk.
Critical evaluation of risk markers and risk assessment methods have become even more important as novel markers of cardiovascular risk are identified by technological advances in genetics, genomics, proteomics, and non-invasive imaging. They have been shown to evaluate the risk of an individual in more depth than the traditional methods and perhaps also provide insights into the unexplored and hidden risks.
However, these novel methods of cardiovascular risk assessments are costly and not readily available and hence they must be judiciously utilised to provide a more individualized and personalised approach so that this strategy is more cost effective.
Biography:
Dr Syed Raza graduated from Aligarh University in India in 1993. After completing his postgraduate degree in Medicine from the same university, he moved to the UK for higher specialist studies. He successfully completed MRCP and CCT and later also awarded Fellow of the Royal College of Physicians of Edinburgh. He was awarded professor John Goodwin prize for outstanding performance in Diploma Cardiology exam at Hammersmith Hospital, University of London in 2001. Dr Raza is Fellow of American College of Cardiology, Fellow of European Society of Cardiology and Fellow of European Society of Cardiovascular Imaging. He is also on the committee of Acute Cardiovascular Care, Heart Failure and Cardiovascular Imaging (European Society of Cardiology ) He is Review author for abstracts for European Society of Cardiology for the past three years. Obtained Diploma certificate in Medical Education from University of Cardiff , Wales in 2015.
Consultant Cardiologist and Head of the department of Medicine at Awali Hospital, Bahrain. He is the regional educational coordinator and examiner for MRCP (PACES) exam for the Royal College of Physicians of Edinburgh. Certified Educational and Clinical supervisor, NHS-UK. He has to his credit numerous publications and he has presented his scientific work in different parts of the world. He is peer review author for some well respected International journals. He is American Board certified in Medical Quality and is involved in patient safety and quality improvement assignments during his current and previous jobs. He participates in key decision making for quality improvement. His special interests are Cardiovascular Imaging, Heart Failure and Acute Cardiovascular Care.
